Status:
COMPLETED
Intravenous Beta-blockade for Improvement of Autonomic Activity
Lead Sponsor:
University Hospital Schleswig-Holstein
Conditions:
Hypertension
Tachycardia
Eligibility:
All Genders
18+ years
Brief Summary
Chronic beta-adrenoceptor blockade is known to improve outcome of high risk patients whereas amelioration of autonomic activity was demonstrated to be a major cause of outcome improvement. Therefore, ...
Eligibility Criteria
Inclusion
- Patients scheduled for coronary artery bypass surgery
- Ejection fraction \> 30 %
- Informed consent
Exclusion
- Emergency cases
- Myocardiac infraction within 4 weeks
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00700466
Start Date
March 1 2008
End Date
November 1 2009
Last Update
January 18 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Schleswig-Holstein, Campus Kiel, Germany
Kiel, Schleswig-Holstein, Germany, 24105